Progress and predictions: AML in 2018. [electronic resource]
Producer: 20190620Description: 337-340 p. digitalISSN:- 1532-1924
- Drug Approval
- High-Throughput Nucleotide Sequencing
- Humans
- Isocitrate Dehydrogenase -- antagonists & inhibitors
- Leukemia, Myeloid, Acute -- drug therapy
- Neoplasm, Residual
- Protein Kinase Inhibitors -- therapeutic use
- United States
- United States Food and Drug Administration
- fms-Like Tyrosine Kinase 3 -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.